Advertisement
Review Article|Articles in Press

Cushing Syndrome and Other Causes of Insulin Resistance in Dogs

Published:March 08, 2023DOI:https://doi.org/10.1016/j.cvsm.2023.01.009

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • European Society of Veterinary Endocrinology
        Project ALIVE.
        (Available at:) (Accessed Dec 5, 2022)
        • Pivonello R.
        • De Leo M.
        • Vitale P.
        • et al.
        Pathophysiology of diabetes mellitus in Cushing's syndrome.
        Neuroendocrinology. 2010; 92: 77-81
        • van Raalte D.H.
        • Diamant M.
        Steroid diabetes: from mechanism to treatment?.
        Neth J Med. 2014; 72: 62-72
        • van Raalte D.H.
        • Brands M.
        • van der Zijl N.J.
        • et al.
        Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.
        Diabetologia. 2011; 54: 2103-2112
        • Rizza R.A.
        • Mandarino L.J.
        • Gerich J.E.
        Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.
        J Clin Endocrinol Metab. 1982; 54: 131-138
        • DeFronzo R.A.
        • Jacot E.
        • Jequier E.
        • et al.
        The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization.
        Diabetes. 1981; 30: 1000-1007
        • Khaleeli A.A.
        • Edwards R.H.
        • Gohil K.
        • et al.
        Corticosteroid myopathy: a clinical and pathological study.
        Clin Endocrinol. 1983; 18: 155-166
        • Ouchi N.
        • Parker J.L.
        • Lugus J.J.
        • et al.
        Adipokines in inflammation and metabolic disease.
        Nat Rev Immunol. 2011; 11: 85-97
        • van Raalte D.H.
        • Ouwens D.M.
        • Diamant M.
        Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?.
        Eur J Clin Invest. 2009; 39: 81-93
        • van Raalte D.H.
        • Kwa K.A.
        • van Genugten R.E.
        • et al.
        Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?.
        Metabolism: Clinical and Experimental. 2013; 62: 568-577
        • Peterson M.E.
        • Nesbitt G.H.
        • Schaer M.
        Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in thirty dogs.
        Journal of the American Veterinary Medical Association. 1981; 178: 66-69
        • Fukuta H.
        • Mori A.
        • Urumuhan N.
        • et al.
        Characterization and comparison of insulin resistance induced by Cushing Syndrome or diestrus against healthy control dogs as determined by euglycemic- hyperinsulinemic glucose clamp profile glucose infusion rate using an artificial pancreas apparatus.
        J Vet Med Sci. 2012; 74: 1527-1530
        • Montgomery T.M.
        • Nelson R.W.
        • Feldman E.C.
        • et al.
        Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
        J Vet Intern Med. 1996; 10: 116-122
        • Miceli D.D.
        • Pignataro O.P.
        • Castillo V.A.
        Concurrent hyperadrenocorticism and diabetes mellitus in dogs.
        Res Vet Sci. 2017; 115: 425-431
        • Yoon S.
        • Fleeman L.M.
        • Wilson B.J.
        • et al.
        Epidemiological study of dogs with diabetes mellitus attending primary care veterinary clinics in Australia.
        Vet Rec. 2020; 187: e22
        • Hess R.S.
        • Saunders M.
        • van Winkle T.J.
        • et al.
        Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993-1998).
        Journal of the American Veterinary Medical Association. 2000; 217: 1166-1173
        • Kline K.E.
        • Walton S.A.
        • Specht A.J.
        • et al.
        Comparison of ophthalmic loteprednol etabonate and prednisolone acetate effects on adrenocortical response to ACTH in dogs.
        Vet Ophthalmol. 2022; 25: 468-475
        • Rankin A.J.
        • KuKanich K.S.
        • Schermerhorn T.
        • et al.
        Evaluation of diabetes mellitus regulation in dogs treated with ophthalmic preparations of prednisolone acetate versus diclofenac sodium.
        American Journal of Veterinary Research. 2019; 80: 1129-1135
        • Behrend E.N.
        • Kooistra H.S.
        • Nelson R.
        • et al.
        Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).
        J Vet Intern Med. 2013; 27: 1292-1304
        • Fink H.
        • Herbert C.
        • Gilor C.
        Pharmacodynamics and pharmacokinetics of insulin detemir and insulin glargine 300 U/mL in healthy dogs.
        Domest Anim Endocrinol. 2018; 64: 17-30
        • Oda H.
        • Mori A.
        • Ishii S.
        • et al.
        Time-action profiles of insulin degludec in healthy dogs and its effects on glycemic control in diabetic dogs.
        J Vet Med Sci. 2018; 80: 1720-1723
        • Gilor C.
        • Fleeman L.M.
        • Fracassi F.
        Insulin glargine U300 in dogs: Clinical experience and simple guidelines. Paper presented at: ACVIM Forum; virtual presentation available Sept 22 to Nov 30. 2022;
        • Gilor C.
        • Fleeman L.M.
        One hundred years of insulin: Is it time for smart?.
        Journal of Small Animal Practice. 2022; 63: 645-660
        • Bennaim M.
        • Shiel R.E.
        • Mooney C.T.
        Diagnosis of spontaneous hyperadrenocorticism in dogs. Part 2: Adrenal function testing and differentiating tests.
        Vet J (London, England 1997). 2019; 252: 105343
        • Teshima T.
        • Hara Y.
        • Takekoshi S.
        • et al.
        Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.
        Domest Anim Endocrinol. 2009; 36: 32-44
        • de Gier J.
        • Wolthers C.H.
        • Galac S.
        • et al.
        Effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane on luteal progesterone production in the dog.
        Theriogenology. 2011; 75: 1271-1279
        • Plows J.F.
        • Stanley J.L.
        • Baker P.N.
        • et al.
        The Pathophysiology of Gestational Diabetes Mellitus.
        Int J Mol Sci. 2018; 19: 3342
        • Kampmann U.
        • Knorr S.
        • Fuglsang J.
        • et al.
        Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview.
        J Diabetes Res. 2019; 2019: 5320156
        • Johnson C.A.
        Glucose homeostasis during canine pregnancy: Insulin resistance, ketosis, and hypoglycemia.
        Theriogenology. 2008; 70: 1418-1423
        • Eigenmann J.E.
        • Eigenmann R.Y.
        • Rijnberk A.
        • et al.
        Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly.
        Acta Endocrinol. 1983; 104: 167-176
        • Fall T.
        • Hamlin H.H.
        • Hedhammar A.
        • et al.
        Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution.
        J Vet Intern Med. 2007; 21: 1209-1216
        • Fall T.
        • Hedhammar A.
        • Wallberg A.
        • et al.
        Diabetes mellitus in elkhounds is associated with diestrus and pregnancy.
        J Vet Intern Med. 2010; 24: 1322-1328
        • Heeley A.M.
        • O’Neill D.G.
        • Davison L.J.
        • et al.
        Diabetes mellitus in dogs attending UK primary-care practices: frequency, risk factors and survival.
        Canine Medicine and Genetics. 2020; 7: 6
        • Carotenuto G.
        • Malerba E.
        • Dolfini C.
        • et al.
        Cushing's syndrome-an epidemiological study based on a canine population of 21,281 dogs.
        Open Vet J. 2019; 9: 27-32
        • Pöppl A.G.
        • Mottin T.S.
        • González F.H.
        Diabetes mellitus remission after resolution of inflammatory and progesterone-related conditions in bitches.
        Res Vet Sci. 2013; 94: 471-473
        • German A.J.
        • Hervera M.
        • Hunter L.
        • et al.
        Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs.
        Domest Anim Endocrinol. 2009; 37: 214-226
        • Verkest K.R.
        • Fleeman L.M.
        • Rand J.S.
        • et al.
        Evaluation of beta-cell sensitivity to glucose and first-phase insulin secretion in obese dogs.
        American Journal of Veterinary Research. 2011; 72: 357-366
        • Verkest K.R.
        • Fleeman L.M.
        • Morton J.M.
        • et al.
        Compensation for obesity-induced insulin resistance in dogs: assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis.
        Domest Anim Endocrinol. 2011; 41: 24-34
        • Verkest K.R.
        • Rand J.S.
        • Fleeman L.M.
        • et al.
        Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs.
        Domest Anim Endocrinol. 2012; 42: 103-112
        • Mattheeuws D.
        • Rottiers R.
        • Kaneko J.J.
        • et al.
        Diabetes mellitus in dogs: Relationship of obesity to glucose tolerance and insulin response.
        American Journal of Veterinary Research. 1984; 45: 98-103